Apyx Gross Profit from 2010 to 2025

APYX Stock

USD 1.35 0.09 7.14%

Apyx Medical Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Apyx Medical makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2000-03-31

Previous Quarter

7 M

Current Value

9 M

Quarterly Volatility

2.2 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 733.6 K, Interest Expense of 6.2 M or Selling General Administrative of 45.3 M, as well as many indicators such as Price To Sales Ratio of 1.11, Dividend Yield of 0.0 or PTB Ratio of 3.75. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.

Check out the analysis of Apyx Medical Correlation against competitors.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Apyx Medical over the last few years. Gross profit is a required income statement account that reflects total revenue of Apyx Medical minus its cost of goods sold. It is profit before Apyx Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Apyx Medical's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 29.36 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Apyx Gross Profit Regression Statistics

	Arithmetic Mean	18,555,981
	Geometric Mean	15,503,719
	Coefficient Of Variation	53.76
	Mean Deviation	8,209,391
	Median	17,915,000
	Standard Deviation	9,975,660
	Sample Variance	99.5T
	Range	31.5M
	R-Value	0.90
	Mean Square Error	19.5T
	R-Squared	0.82
	Slope	1,893,765
	Total Sum of Squares	1492.7T

Apyx Gross Profit History

	2025	30.8 M
	2024	29.4 M
	2023	33.8 M
	2022	29.1 M
	2021	33.6 M
	2020	17.5 M
	2019	19.1 M

Other Fundumenentals of Apyx Medical

Gross Profit Margin

Apyx Medical Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.83	0.28	-0.66	0.21	0.64	0.57	-0.31	0.27	0.95	0.64	-0.65	0.06	0.36	0.53	0.88	-0.53	0.71	-0.7	-0.87	0.93	0.94	0.08
Total Stockholder Equity	0.83		0.47	-0.66	0.6	0.28	0.36	-0.33	-0.19	0.8	0.65	-0.49	0.02	0.19	0.24	0.92	-0.51	0.37	-0.5	-0.64	0.85	0.82	-0.22
Current Deferred Revenue	0.28	0.47		-0.34	0.45	0.09	-0.08	-0.24	-0.39	0.2	0.18	0.08	-0.09	0.15	-0.16	0.26	0.12	0.05	0.01	0.01	0.23	0.18	-0.48
Net Debt	-0.66	-0.66	-0.34		-0.12	-0.45	-0.58	0.24	-0.18	-0.71	-0.57	0.61	-0.13	-0.21	-0.65	-0.74	0.47	-0.53	0.53	0.68	-0.68	-0.67	-0.21
Retained Earnings	0.21	0.6	0.45	-0.12		-0.36	-0.4	0.12	-0.82	0.06	0.21	0.16	-0.02	-0.14	-0.46	0.36	0.04	-0.42	0.12	0.12	0.27	0.2	-0.8
Accounts Payable	0.64	0.28	0.09	-0.45	-0.36		0.74	-0.13	0.49	0.59	0.45	-0.62	0.21	0.32	0.75	0.39	-0.39	0.88	-0.63	-0.77	0.47	0.5	0.28
Net Receivables	0.57	0.36	-0.08	-0.58	-0.4	0.74		-0.31	0.53	0.66	0.63	-0.75	0.15	0.27	0.89	0.51	-0.58	0.84	-0.68	-0.83	0.5	0.54	0.49
Good Will	-0.31	-0.33	-0.24	0.24	0.12	-0.13	-0.31		-0.27	-0.37	-0.23	-0.12	0.79	-0.72	-0.3	-0.17	0.05	-0.19	0.13	0.17	-0.19	-0.19	-0.2
Total Liab	0.27	-0.19	-0.39	-0.18	-0.82	0.49	0.53	-0.27		0.43	0.02	-0.45	-0.02	0.22	0.66	0.09	-0.2	0.57	-0.39	-0.48	0.25	0.32	0.85
Total Current Assets	0.95	0.8	0.2	-0.71	0.06	0.59	0.66	-0.37	0.43		0.62	-0.77	0.1	0.25	0.62	0.91	-0.61	0.72	-0.72	-0.9	0.96	0.97	0.29
Short Term Debt	0.64	0.65	0.18	-0.57	0.21	0.45	0.63	-0.23	0.02	0.62		-0.52	0.07	0.26	0.51	0.65	-0.5	0.49	-0.55	-0.67	0.62	0.61	0.0
Intangible Assets	-0.65	-0.49	0.08	0.61	0.16	-0.62	-0.75	-0.12	-0.45	-0.77	-0.52		-0.61	0.24	-0.7	-0.74	0.64	-0.73	0.72	0.88	-0.76	-0.78	-0.42
Common Stock	0.06	0.02	-0.09	-0.13	-0.02	0.21	0.15	0.79	-0.02	0.1	0.07	-0.61		-0.76	0.06	0.25	-0.41	0.28	-0.24	-0.27	0.21	0.22	0.03
Property Plant Equipment	0.36	0.19	0.15	-0.21	-0.14	0.32	0.27	-0.72	0.22	0.25	0.26	0.24	-0.76		0.31	0.06	0.04	0.32	-0.18	-0.21	0.09	0.1	0.12
Long Term Debt	0.53	0.24	-0.16	-0.65	-0.46	0.75	0.89	-0.3	0.66	0.62	0.51	-0.7	0.06	0.31		0.41	-0.35	0.74	-0.64	-0.79	0.48	0.52	0.55
Net Tangible Assets	0.88	0.92	0.26	-0.74	0.36	0.39	0.51	-0.17	0.09	0.91	0.65	-0.74	0.25	0.06	0.41		-0.67	0.55	-0.65	-0.82	0.95	0.94	0.1
Long Term Debt Total	-0.53	-0.51	0.12	0.47	0.04	-0.39	-0.58	0.05	-0.2	-0.61	-0.5	0.64	-0.41	0.04	-0.35	-0.67		-0.63	0.52	0.63	-0.55	-0.56	-0.3
Capital Surpluse	0.71	0.37	0.05	-0.53	-0.42	0.88	0.84	-0.19	0.57	0.72	0.49	-0.73	0.28	0.32	0.74	0.55	-0.63		-0.71	-0.85	0.57	0.62	0.48
Deferred Long Term Liab	-0.7	-0.5	0.01	0.53	0.12	-0.63	-0.68	0.13	-0.39	-0.72	-0.55	0.72	-0.24	-0.18	-0.64	-0.65	0.52	-0.71		0.82	-0.69	-0.71	-0.32
Short Long Term Debt	-0.87	-0.64	0.01	0.68	0.12	-0.77	-0.83	0.17	-0.48	-0.9	-0.67	0.88	-0.27	-0.21	-0.79	-0.82	0.63	-0.85	0.82		-0.85	-0.88	-0.4
Net Invested Capital	0.93	0.85	0.23	-0.68	0.27	0.47	0.5	-0.19	0.25	0.96	0.62	-0.76	0.21	0.09	0.48	0.95	-0.55	0.57	-0.69	-0.85		1.0	0.12
Net Working Capital	0.94	0.82	0.18	-0.67	0.2	0.5	0.54	-0.19	0.32	0.97	0.61	-0.78	0.22	0.1	0.52	0.94	-0.56	0.62	-0.71	-0.88	1.0		0.18
Capital Stock	0.08	-0.22	-0.48	-0.21	-0.8	0.28	0.49	-0.2	0.85	0.29	0.0	-0.42	0.03	0.12	0.55	0.1	-0.3	0.48	-0.32	-0.4	0.12	0.18

Click cells to compare fundamentals

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	29.4 M	30.8 M
Gross Profit Margin	0.61	0.38

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC